221 related articles for article (PubMed ID: 24320558)
1. Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
Brewer JD; Habermann TM; Shanafelt TD
Int J Dermatol; 2014 Mar; 53(3):267-74. PubMed ID: 24320558
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
4. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin lymphoma and skin cancer: A dangerous combination.
Otley CC
Australas J Dermatol; 2006 Nov; 47(4):231-6. PubMed ID: 17034463
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
7. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
Levi F; Randimbison L; Te VC; La Vecchia C
Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
[TBL] [Abstract][Full Text] [Related]
9. Aggressive behavior of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
Tomaszewski JM; Gavriel H; Link E; Boodhun S; Sizeland A; Corry J
Laryngoscope; 2014 Sep; 124(9):2043-8. PubMed ID: 24402728
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients.
Hock BD; McIntosh ND; McKenzie JL; Pearson JF; Simcock JW; MacPherson SA
Intern Med J; 2016 Dec; 46(12):1414-1421. PubMed ID: 27664975
[TBL] [Abstract][Full Text] [Related]
11. Skin Cancer and Immunosuppression.
Collins L; Quinn A; Stasko T
Dermatol Clin; 2019 Jan; 37(1):83-94. PubMed ID: 30466691
[TBL] [Abstract][Full Text] [Related]
12. Nonmelanoma skin cancer.
Dubas LE; Ingraffea A
Facial Plast Surg Clin North Am; 2013 Feb; 21(1):43-53. PubMed ID: 23369588
[TBL] [Abstract][Full Text] [Related]
13. Common skin cancers in older adults: approach to diagnosis and management.
Council ML
Clin Geriatr Med; 2013 May; 29(2):361-72. PubMed ID: 23571033
[TBL] [Abstract][Full Text] [Related]
14. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?
Bloom R; Amber KT; Nouri K
Australas J Dermatol; 2016 Aug; 57(3):e114-6. PubMed ID: 25801041
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
16. Optimal management of skin cancer in immunosuppressed patients.
Brin L; Zubair AS; Brewer JD
Am J Clin Dermatol; 2014 Aug; 15(4):339-56. PubMed ID: 25015705
[TBL] [Abstract][Full Text] [Related]
17. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
19. Skin cancers of the hand and upper extremity.
Ilyas EN; Leinberry CF; Ilyas AM
J Hand Surg Am; 2012 Jan; 37(1):171-8. PubMed ID: 22196297
[TBL] [Abstract][Full Text] [Related]
20. High-risk cutaneous malignancies and immunosuppression: Challenges for the reconstructive surgeon in the renal transplant population.
Kearney L; Hogan D; Conlon P; Roche M; O'Neill JP; O'Sullivan JB
J Plast Reconstr Aesthet Surg; 2017 Jul; 70(7):922-930. PubMed ID: 28457679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
